Alan A. Musso

Chief Financial Officer, GYRE THERAPEUTICS, INC.

Companies

Research Alliance Corp IVBoard member Jul 10, 2026 to now¹
Rein Therapeutics, Inc.Board member Nov 2, 2023 to now²
Fulcrum Therapeutics (United States)Chief financial officer Aug 9, 2023 to now³
BELLICUM PHARMACEUTICALS, INCChief financial officer Dec 17, 2014 to Jul 5, 2018⁴
GYRE THERAPEUTICS, INC.Chief financial officer Apr 11, 2006 to Oct 21, 2014⁵

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Fulcrum Therapeutics (United States) FULC0 shares⁶Aug 9, 2023

As of each latest filing. The line shows shares held over time.

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARResearch Alliance Corp IV, Board member
2
SEC EDGARRein Therapeutics, Inc., Board member
3
SEC EDGARFulcrum Therapeutics (United States), Chief financial officer
4
SEC EDGARBELLICUM PHARMACEUTICALS, INC, Chief financial officer
5
SEC EDGARGYRE THERAPEUTICS, INC., Chief financial officer
6
SEC EDGARFulcrum Therapeutics (United States) shares after the filing of Aug 9, 2023